Overview

Endowing Extracellular Vesicles with Targeting Specificity

Extracellular vesicles (EVs) are particles naturally released by cells, which have a lipid bilayer structure. Because EVs have the advantages of low tumorigenic risk, weak autoimmune response and toxicity, small size, low complexity of structure and composition, easy production and preservation, etc., EVs have become a hot topic for research, transformation, and modification. In order to improve the efficiency of EV targeting lesions, a large number of researchers have immobilized molecules with targeting functions on the surface of EV, so that EVs can gather in target tissues or cells more efficiently, which improves the usage efficiency of drugs encapsulated in EV. Common targeting molecules include peptides, nucleic acid aptamers, superparamagnetic nanoparticles, etc. Commonly used modification methods include endogenous modification and exogenous modification. Creative Biolabs has been paying attention to and summarizing molecules with targeting functions that can be constructed on EV and can provide the best EV targeting modification services according to customer needs.

Fig.1 Strategies for the membrane modification and targeted delivery of EVs.^1,2

Services

Endogenous Targeting Modification Service for Extracellular Vesicle

The endogenous targeting modification of EV is carried out on donor cells through genetic recombination, and these engineered donor cells can release EVs with targeting molecules. Specifically, peptides or proteins with targeting functions are fused to EV membrane proteins, so that these targeting molecules are displayed on the outside of EV membranes. Commonly used EV membrane proteins for anchoring targeting molecules include Lamp2b, tetraspanins (such as CD63, CD9, CD81, etc.), the C1C2 domain of lactadherin, etc. At present, there is a set of relatively mature and general operating methods for targeting the modification of EV using genetic means. By establishing stable cell lines, targeted EVs can be produced in large quantities within a long period of time.

Exogenous Targeting Modification Service for Extracellular Vesicle

Exogenous targeting modification of EV is carried out on isolated EVs by chemical methods. The commonly used modification method is non-covalent binding relying on hydrophobic interactions or receptor-ligand interactions. Hydrophobic interaction-dependent modification needs to attach a hydrophobic tail to the targeting molecule so that the targeting molecule can be modified on the EV surface through the hydrophobic interaction between the tail and the EV membrane. The modification that depends on the receptor-ligand interaction needs to connect a receptor or a ligand to the EV membrane protein and the targeting molecule, respectively, so that the targeting molecule can be modified on the EV surface through the complementary pairing of the receptor and the ligand. Compared with endogenous targeting modification methods, exogenous targeting modification methods can modify more diverse molecules on the surface of EV, such as nucleic acids, lipids, and nanoparticles.

Features

• Dual Surface Modification Strategies
• Enhanced Targeting Specificity
• Customizable Modifications for Diverse Applications
• Scalable and Reproducible Production

Creative Biolabs has extensive experience in modifying EV and has established a library of targeted molecules that can be modified on the surface of EV. If you are interested in EV targeting modification services, please contact us with your specific idea. Our professional team will provide you with EV isolation and characterization services and formulate the most suitable EV targeting modification plan based on experience. In addition, we also provide EV loading services, EV profiling services, and EV functional research and verification services to further verify the efficiency of targeted EVs for you.

FAQs

References

1. Liu, Q.; et al. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification. Journal of Nanobiotechnology. 2023, 21(1):334.
2. Distributed under Open Access license CC BY 4.0, without modification.

• Loading
• Labeling